Retatrutide is an investigational medication currently undergoing human clinical trials and is not approved for general use
Cognitive Enhancement Studies Cognitive improvement studies in 28-month-old mice (equivalent to elderly humans) using 10 mg/kg body weight administered 5x per week for 3 weeks demonstrated: Significantly faster escape hole finding in Box Maze tests (trials 4 and 5) Evidence of decreased brain inflammation Increased histone deacetylase 2 labeling indicating epigenetic pathway activation Preliminary reversal of age-related cognitive impairment Pain and Anxiety Modulation Anti-pain effects in mice at 0.5 mg/kg showed efficacy comparable to cimetidines human analgesic effects, affecting 7 anti-pain genes (increased) and 2 genes (decreased), with upregulated opioid receptors and related pain-modulating pathways
No insurance approval, no membership fees, and no flat per-compound pricing increases mean predictable, affordable access to the same active compounds used in brand-name GLP-1 therapies
She specializes in holistic weight management and creating custom treatment plans to help patients reach their health goals safely
Provider consultation: Some platforms include an initial and/or ongoing telehealth consultation in the medication price
Weight Loss Comparison: Metformin vs Ozempic Both metformin and Ozempic can promote weight loss as a side effect in individuals with type 2 diabetes who are overweight or obese, but the magnitude of results differs significantly